Page last updated: 2024-09-03

almotriptan and Recrudescence

almotriptan has been researched along with Recrudescence in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (80.00)	29.6817
2010's	2 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Pascual, J	2
Clissold, SP; Díaz-Insa, S; Lanteri-Minet, M; Leone, M; Vila, C	1
McGown, CC; Pascual, J; Vila, C	1
Cabarrocas, X; Dowson, AJ; Laínez, JM; Massiou, H	1
Diener, HC	1
Cunha, L; de Klippel, N; Diaz-Insa, S; Falques, M; Fortea, J; Geraud, G; Goadsby, PJ; Gobel, H; Ivanoff, N; Zanchin, G	1
Ferrari, MD; Goadsby, PJ; Lipton, RB; Roon, KI	1
Cabarrocas, X; Pascual, J	1
Dahlöf, CG; Dodick, D; Dowson, AJ; Pascual, J	1

Reviews

5 review(s) available for almotriptan and Recrudescence

Article	Year
Almotriptan in triptan-naïve patients: new evidence of benefits. Cephalalgia : an international journal of headache, 2008, Volume: 28 Suppl 2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Disease Management; Europe; Humans; Meta-Analysis as Topic; Migraine Disorders; Patient Satisfaction; Practice Patterns, Physicians'; Prescriptions; Recurrence; Time Factors; Treatment Outcome; Tryptamines	2008
Almotriptan: a review of 10 years' clinical experience. Expert review of neurotherapeutics, 2010, Volume: 10, Issue:10 Topics: Dose-Response Relationship, Drug; Early Diagnosis; Female; Humans; Male; Migraine Disorders; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines	2010
Almotriptan: pharmacological differences and clinical results. Current medical research and opinion, 2001, Volume: 17 Suppl 1 Topics: Administration, Oral; Humans; Indoles; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Tryptamines	2001
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet (London, England), 2001, Nov-17, Volume: 358, Issue:9294 Topics: Acute Disease; Administration, Oral; Humans; Indoles; Migraine Disorders; Pyrrolidines; Randomized Controlled Trials as Topic; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Treatment Outcome; Triazoles; Tryptamines	2001
How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials. Headache, 2002, Volume: 42, Issue:2 Topics: Humans; Indoles; Migraine Disorders; Placebos; Randomized Controlled Trials as Topic; Recurrence; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines	2002

Trials

4 trial(s) available for almotriptan and Recrudescence

Article	Year
Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the START study. International journal of clinical practice, 2010, Volume: 64, Issue:7 Topics: Acute Disease; Adult; Analgesics; Disabled Persons; Female; Humans; Male; Migraine Disorders; Patient Education as Topic; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2010
Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial. Cephalalgia : an international journal of headache, 2002, Volume: 22, Issue:6 Topics: Administration, Oral; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Multicenter Studies as Topic; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines	2002
Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan. Cephalalgia : an international journal of headache, 2008, Volume: 28, Issue:4 Topics: Activities of Daily Living; Acute Disease; Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine with Aura; Migraine without Aura; Neck Pain; Placebos; Recurrence; Serotonin Receptor Agonists; Severity of Illness Index; Shoulder Pain; Time Factors; Treatment Outcome; Tryptamines	2008
Within-patient early versus delayed treatment of migraine attacks with almotriptan: the sooner the better. Headache, 2002, Volume: 42, Issue:1 Topics: Administration, Oral; Adult; Drug Administration Schedule; Humans; Indoles; Longitudinal Studies; Middle Aged; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2002

Other Studies

1 other study(ies) available for almotriptan and Recrudescence

Article	Year
Consistent efficacy, tolerability, and high levels of satisfaction with almotriptan 12.5 mg when used to treat multiple migraine attacks in routine clinical practice. Headache, 2005, Volume: 45, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines	2005

Article

Year

Consistent efficacy, tolerability, and high levels of satisfaction with almotriptan 12.5 mg when used to treat multiple migraine attacks in routine clinical practice.

Headache, 2005, Volume: 45, Issue:6

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Indoles; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines

2005